Lexaria Bioscience (LEXX) Short-term Investments (2018 - 2026)
Lexaria Bioscience (LEXX) recorded Short-term Investments of $142,103 in fiscal Q3 2026 (quarter ended May 31, 2026), up 323.7% from $33,540 a year earlier and up 0.6% from the prior quarter.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Short-term Investments (2018 - 2026) Analysis & Trends
At the end of FY2025 (ended Aug 31, 2025), Lexaria Bioscience reported Short-term Investments of $143,267, up 156.7% from FY2024.
- Annual Short-term Investments has a five-year compound annual growth rate of 49.3% (FY2020 to FY2025).
- Across earlier fiscal years, Short-term Investments came in at $55,807 in FY2024 (-55.6%), $125,642 in FY2023 (-63.8%), $347,335 in FY2022 (-58.3%) and $833,841 in FY2021.
- Quarterly Short-term Investments has ranged from $33,540 in fiscal Q3 2025 to $833,841 in fiscal Q4 2021 over the past five years.
- On a year-over-year basis, Short-term Investments has increased for four consecutive quarters, with growth averaging 85.9% over the last eight quarters.
- Peak year-over-year performance for Short-term Investments in the last five years was growth of 323.7% in fiscal Q3 2026, against a decline of 82.8% in fiscal Q3 2024 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $141,266 (Q2 2026), $143,267 (Q1 2026) and $143,267 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Lexaria Bioscience | 3.04 Mn | -12.61 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 142,103.00 |
| Feb 28, 2026 | 141,266.00 |
| Nov 30, 2025 | 143,267.00 |
| Aug 31, 2025 | 143,267.00 |
| May 31, 2025 | 33,540.00 |
| Feb 28, 2025 | 73,915.00 |
| Nov 30, 2024 | 39,875.00 |
| Aug 31, 2024 | 55,807.00 |
| May 31, 2024 | 46,307.00 |
| Feb 29, 2024 | 87,699.00 |
| Nov 30, 2023 | 72,427.00 |
| Aug 31, 2023 | 125,642.00 |
| May 31, 2023 | 269,560.00 |
| Feb 28, 2023 | 267,704.00 |
| Nov 30, 2022 | 269,707.00 |
| Aug 31, 2022 | 347,335.00 |
| May 31, 2022 | 288,032.00 |
| Feb 28, 2022 | 552,317.00 |
| Nov 30, 2021 | 493,424.00 |
| Aug 31, 2021 | 833,841.00 |
API Access
Lexaria Bioscience Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();